Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$142.10
+0.75%
Mkt Cap $9.03B
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (28 analysts)
$176.29
Range $165.00 – $190.00
Implied Upside
+24.1%
Consensus $176.29 vs current $142.10